Virginia Retirement Systems Et Al Arcutis Biotherapeutics, Inc. Transaction History
Virginia Retirement Systems Et Al
- $10.1 Billion
- Q3 2023
A detailed history of Virginia Retirement Systems Et Al transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 29,500 shares of ARQT stock, worth $407,395. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,500Holding current value
$407,395% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARQT
# of Institutions
197Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC11.7MShares$161 Million0.07% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$151 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$148 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$121 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$119 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $831M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...